Page last updated: 2024-10-30

metformin and Gait Disorders, Animal

metformin has been researched along with Gait Disorders, Animal in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
" Further studies are required to define appropriate selection of subjects warranting therapy, dosing schedule and pharmacokinetics."5.35The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance. ( Durham, AE; Newton, JE; Rendle, DI, 2008)
" Further studies are required to define appropriate selection of subjects warranting therapy, dosing schedule and pharmacokinetics."1.35The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance. ( Durham, AE; Newton, JE; Rendle, DI, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durham, AE1
Rendle, DI1
Newton, JE1

Other Studies

1 other study available for metformin and Gait Disorders, Animal

ArticleYear
The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance.
    Equine veterinary journal, 2008, Volume: 40, Issue:5

    Topics: Animals; Area Under Curve; Blood Glucose; Dose-Response Relationship, Drug; Drug Administration Sche

2008